Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French : 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE
Reflecting on a talk from our Keynote speaker - Mark Wilson: Navigating Innovation in a Slow-Moving Pharma Industry

Reflecting on a talk from our Keynote speaker - Mark Wilson: Navigating Innovation in a Slow-Moving Pharma Industry

Georgia Lewis: 26 March 2026

Mark Wilson - Presentation at UK Pharmaceutical & MedTech Innovations event.ISPE UK Affiliate - 12/2/2026 Listening to Mark’s reflections on his 20...

Read More
Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

Optimising Cryovial Filling and Cryopreservation for Reliable Cell Functionality

3P innovation: 18 March 2026

An Integrated Equipment Workflow for Consistent Post-Thaw Viability and Function Recovery

Read More
The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

The challenges of developing combination products: Regulatory complexity and the case for a holistic development strategy

Dr. Dave Seaward: 15 February 2026

Drug–device combination products are becoming a defining feature of modern pharmaceutical portfolios, shaping how therapies differentiate, extend...

Read More